Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kardigan
Biotech
UPDATED: Kardigan buttons up $400M upsized IPO for phase 3 push
Kardigan’s IPO haul came in 14% above expectations, grossing $400 million after the biotech upsized the offering and hit the top end of its range.
Nick Paul Taylor
,
Will Maddox
Jun 18, 2026 7:28am
Kardigan plans to bring in cozy $320M haul from upcoming IPO
Jun 11, 2026 8:14am
Kardigan itching for IPO to fund late-stage cardio pipeline
May 27, 2026 4:57am
Kardigan hypertension drug tangles biomarker win with BP miss
Mar 30, 2026 5:11am
Biotech's top money raisers: 2025
Mar 2, 2026 6:30am
PitchBook expects disciplined biopharma VC recovery in 2026
Feb 16, 2026 12:01am
